Avonex

Celgene touts ozanimod MS data, but disability benefit weak over rival med
Fierce Biotech
Mon, 05/22/17 - 09:41 am
Celgene
ozanimod
MS
multiple sclerosis
Biogen
Avonex
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
Biogen Inc MS Drugs: Deadly Cash Cows?
Bidness, ETC
Fri, 08/5/16 - 11:28 am
Biogen
MS
multiple sclerosis
Tecfidera
Avonex
Tysabri
Plegridy
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Fierce Pharma
Wed, 06/22/16 - 07:08 pm
MS
multiple sclerosis
payers
Sanofi
Aubagio
Teva Pharmaceutical
Copaxone
Biogen
Tecfidera
Avonex
Wall Street Journal Surprised That Pharma Cos Make Out Like Bandits From Patent System
Forbes
Tue, 10/6/15 - 08:16 am
patents
generics
Avonex
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
The Fly on the Wall
Fri, 05/23/14 - 06:58 am
Biogen Idec
Tysabri
Avonex
Tecfidera
Eloctate
Alprolix
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Is Biogen Too Good To Be True?
Seeking Alpha
Tue, 09/18/12 - 04:44 pm
BiogenIdec
Avonex
Tysabri
Fampyra
Fumaderm
Biogen, Bayer MS Drugs Aren’t Cost Effective, Study Says
Bloomberg
Thu, 07/21/11 - 12:19 pm
MS
multiple sclerosis
Biogen Idec
Bayer
Avonex
Betaseron
Biogen’s 'Avonex Pen' wins tentative EU nod
Bizjournals.com
Tue, 04/19/11 - 11:18 am
Biogen Idec
Avonex
MS
multiple sclerosis
Europe
Avonex pen
Biotech Firms Fight Generics
WSJ Online
Thu, 01/13/11 - 01:14 pm
generics
biotech
Amgen
Pfizer
Enbrel
Epogen
anemia
Biogen Idec
MS
Avonex
multiple sclerosis
arthritis
Biogen Starts Patient Enrollment
Yahoo/Zacks.com
Wed, 05/26/10 - 11:11 am
Biogen Idec
Abbott Laboratories
Acorda Therapeutics
daclizumab
Avonex
MS